Cargando…

Breast Tumour Kinase (Brk/PTK6) Contributes to Breast Tumour Xenograft Growth and Modulates Chemotherapeutic Responses In Vitro

Breast tumour kinase (Brk/PTK6) is overexpressed in up to 86% of breast cancers and is associated with poorer patient outcomes. It is considered a potential therapeutic target in breast cancer, even though the full spectrum of its kinase activity is not known. This study investigated the role of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burmi, Rajpal S., Box, Gary M., Wazir, Umar, Hussain, Haroon A., Davies, Julie A., Court, William J., Eccles, Suzanne A., Jiang, Wen G., Mokbel, Kefah, Harvey, Amanda J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950834/ https://www.ncbi.nlm.nih.gov/pubmed/35327957 http://dx.doi.org/10.3390/genes13030402

Ejemplares similares

Role of the Brk tyrosine kinase in breast cancer progression
por: Harvey, AJ, et al.
Publicado: (2006)

Brk/PTK6 and Involucrin Expression May Predict Breast Cancer Cell Responses to Vitamin D3
por: Box, Carol, et al.
Publicado: (2023)

Breast tumor kinase (Brk/PTK6) plays a role in the differentiation of primary keratinocytes
por: Tupper, J., et al.
Publicado: (2011)

PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors
por: Peng, Maoyu, et al.
Publicado: (2014)

Breast Auto-Augmentation: A Versatile Method of Breast Rehabilitation—A Retrospective Series of 107 Procedures
por: Kirwan, Laurence, et al.
Publicado: (2015)

Locoregional therapy of the primary tumour in de novo stage IV breast cancer in 216 066 patients: A meta-analysis
por: Gera, Ritika, et al.
Publicado: (2020)

The Clinical Implications of Poly Implant Prothèse Breast Implants: An Overview
por: Wazir, Umar, et al.
Publicado: (2015)

Brk expression may affect the differentiation status of breast cancer cells
por: Harvey, AJ, et al.
Publicado: (2008)

The Evolving Role of Radiofrequency Guided Localisation in Breast Surgery: A Systematic Review
por: Tayeh, Salim, et al.
Publicado: (2021)

Simultaneous Salvage Auto-augmentation: Contemporary Strategy for Management of the Breast Explantation Patient
por: Kirwan, Laurence, et al.
Publicado: (2023)

Are online prediction tools a valid alternative to genomic profiling in the context of systemic treatment of ER-positive breast cancer?
por: Wazir, Umar, et al.
Publicado: (2017)

Breast Lipofilling: A Review of Current Practice
por: Kasem, Abdul, et al.
Publicado: (2015)

Brk/PTK6 Sustains Activated EGFR Signaling through Inhibiting EGFR Degradation and Transactivating EGFR
por: Li, X, et al.
Publicado: (2012)

Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma
por: Liu, Xue-Kui, et al.
Publicado: (2013)

Tumour suppressor function of MDA-7/IL-24 in human breast cancer
por: Patani, Neill, et al.
Publicado: (2010)

Omitting Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy for Clinically Node Negative HER2 Positive and Triple Negative Breast Cancer: A Pooled Analysis
por: Alamoodi, Munaser, et al.
Publicado: (2023)

Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review
por: Wazir, Umar, et al.
Publicado: (2016)

Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK
por: Lofgren, Kristopher A, et al.
Publicado: (2011)

Putting the BRK on breast cancer: From molecular target to therapeutics
por: Ang, Hui Li, et al.
Publicado: (2021)

The clinicopathological significance of lamin A/C, lamin B1 and lamin B receptor mRNA expression in human breast cancer
por: Wazir, Umar, et al.
Publicado: (2013)

Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer
por: Sasi, Walid, et al.
Publicado: (2010)

Reflector-Guided Localisation of Non-Palpable Breast Lesions: A Prospective Evaluation of the SAVI SCOUT(®) System
por: Wazir, Umar, et al.
Publicado: (2021)

Pathologic Response of Associated Ductal Carcinoma In Situ to Neoadjuvant Systemic Therapy: A Systematic Review
por: Wazir, Umar, et al.
Publicado: (2022)

Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction.
por: Modjtahedi, H., et al.
Publicado: (1993)

SAT-133 Breast Tumor Kinase (Brk/PTK6) Mediates Triple Negative Breast Cancer Cell Migration and Taxol Resistance via SH2 Domain-Dependent Activation of RhoA and AhR
por: Dwyer, Amy Renee, et al.
Publicado: (2020)

The distribution of the apparent diffusion coefficient as an indicator of the response to chemotherapeutics in ovarian tumour xenografts
por: Tourell, Monique C., et al.
Publicado: (2017)

Identification of genes involved in the formation of lymph node metastasis from human tumour xenograft models of breast cancer
por: Paon, L, et al.
Publicado: (2008)

Stabilization of breast cancer xenograft tumour neovasculature by angiopoietin-1
por: Tian, S, et al.
Publicado: (2002)

The effect of tirapazamine (SR-4233) alone or combined with chemotherapeutic agents on xenografted human tumours.
por: Lartigau, E., et al.
Publicado: (1996)

The role of Herceptin in early breast cancer
por: Subramanian, Ashok, et al.
Publicado: (2008)

Gene expression in oestrogen-dependent human breast cancer xenograft tumours.
por: Thompson, A. M., et al.
Publicado: (1990)

Patient-derived tumour xenografts for breast cancer drug discovery
por: Cassidy, John W, et al.
Publicado: (2016)

Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update
por: Mokbel, Ramia, et al.
Publicado: (2006)

The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models
por: Holt, S V, et al.
Publicado: (2012)

Wilms’ tumour and chemotherapeutic access
por: Yasri, Sora, et al.
Publicado: (2015)

Exploring the interface zone in breast cancer: implications for surgical strategies and beyond
por: Mokbel, Kefah, et al.
Publicado: (2023)

BrkAutoDisplay: functional display of multiple exogenous proteins on the surface of Escherichia coli by using BrkA autotransporter
por: Sun, Fang, et al.
Publicado: (2015)

Evolving Trends in Breast Surgery: Oncoplastic to Onco-Aesthetic Surgery
por: Carmichael, Amtul R, et al.
Publicado: (2016)

Locoregional therapy in de novo metastatic breast cancer. The unanswered question
por: Cardoso, Maria-Joao, et al.
Publicado: (2021)

Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours
por: Beloueche-Babari, M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7771d75nrihb4nvf41bnc5ncph